Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.

M Degerman Gunnarsson, M Lindau, Alexander Santillo, A Wall, H Engler, L Lannfelt, H Basun, L Kilander

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

214 Nedladdningar (Pure)

Sammanfattning

There is an overlap regarding Pittsburgh compound B (PIB) retention in patients clinically diagnosed as Alzheimer's disease (AD) and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a mixed cohort of patients with neurodegenerative dementia of mild severity regarding neuropsychological test performance and regional cerebral glucose metabolism measured with [(18)F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET).
Originalspråkengelska
Sidor (från-till)472-481
TidskriftDementia and Geriatric Cognitive Disorders Extra
Volym3
Nummer1
DOI
StatusPublished - 2013

Bibliografisk information

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Department of Psychogeriatrics (013304000)

Ämnesklassifikation (UKÄ)

  • Psykiatri
  • Geriatrik

Fingeravtryck

Utforska forskningsämnen för ”Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här